Profenamine: Difference between revisions
Jump to navigation
Jump to search
m Protected "Profenamine": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)) |
No edit summary |
||
Line 1: | Line 1: | ||
{{ | |||
|IUPAC_name=''N'',''N''-diethyl-1-(10''H''-phenothiazin-10-yl)propan-2-amine | {{Drugbox | ||
|image=Profenamine.svg | | verifiedrevid = 464215203 | ||
| IUPAC_name = ''N'',''N''-diethyl-1-(10''H''-phenothiazin-10-yl)propan-2-amine | |||
| | | image = Profenamine.svg | ||
| | |||
<!--Clinical data--> | |||
| tradename = | |||
| Drugs.com = {{drugs.com|international|profenamine}} | |||
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> | |||
| pregnancy_US = <!-- A / B / C / D / X --> | |||
| | | legal_AU = <!-- Unscheduled / S2 / S4 / S8 --> | ||
| | | legal_UK = <!-- GSL / P / POM / CD --> | ||
| legal_US = <!-- OTC / Rx-only --> | |||
<!--Pharmacokinetic data--> | |||
|pregnancy_AU=<!-- A / B1 / B2 / B3 / C / D / X --> | | protein_bound = 93% | ||
|pregnancy_US=<!-- A / B / C / D / X --> | | elimination_half-life = 1 to 2 hours | ||
|legal_AU=<!-- Unscheduled / S2 / S4 / S8 --> | <!--Identifiers--> | ||
|legal_UK=<!-- GSL / P / POM / CD --> | | CASNo_Ref = {{cascite|correct|CAS}} | ||
|legal_US=<!-- OTC / Rx-only --> | | CAS_number_Ref = {{cascite|correct|??}} | ||
| | | CAS_number = 1094-08-2 | ||
| | | ATC_prefix = N04 | ||
| ATC_suffix = AA05 | |||
| PubChem = 3290 | |||
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} | |||
| DrugBank = DB00392 | |||
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} | |||
| ChemSpiderID = 3174 | |||
| UNII_Ref = {{fdacite|correct|FDA}} | |||
| UNII = O00T1I1VRN | |||
| ChEBI_Ref = {{ebicite|correct|EBI}} | |||
| ChEBI = 313639 | |||
| ChEMBL_Ref = {{ebicite|correct|EBI}} | |||
| ChEMBL = 1206 | |||
<!--Chemical data--> | |||
| C=19 | H=24 | N=2 | S=1 | |||
| molecular_weight = 312.473 g/mol | |||
| smiles = S2c1ccccc1N(c3c2cccc3)CC(N(CC)CC)C | |||
| InChI = 1/C19H24N2S/c1-4-20(5-2)15(3)14-21-16-10-6-8-12-18(16)22-19-13-9-7-11-17(19)21/h6-13,15H,4-5,14H2,1-3H3 | |||
| InChIKey = CDOZDBSBBXSXLB-UHFFFAOYAV | |||
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} | |||
| StdInChI = 1S/C19H24N2S/c1-4-20(5-2)15(3)14-21-16-10-6-8-12-18(16)22-19-13-9-7-11-17(19)21/h6-13,15H,4-5,14H2,1-3H3 | |||
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} | |||
| StdInChIKey = CDOZDBSBBXSXLB-UHFFFAOYSA-N | |||
}} | }} | ||
{{ | '''Profenamine''' ([[International Nonproprietary Name|INN]], trade names '''Parsidol''', '''Parsidan''', '''Parkin'''), also known as '''ethopropazine''' ([[British Approved Name|BAN]]), is a [[phenothiazine]] [[chemical derivative|derivative]] used as an [[antiparkinsonian]] agent that has [[anticholinergic]], [[antihistamine]], and [[antiadrenergic]] actions. It is also used in the alleviation of the [[extrapyramidal syndrome]] induced by drugs such as other phenothiazine compounds, but, like other compounds with antimuscarinic properties, is of no value against [[tardive dyskinesia]]. | ||
{{ | == References == | ||
{{Reflist}} | |||
{{Antiparkinson}} | |||
{{Adrenergics}} | |||
{{Cholinergics}} | |||
{{Histaminergics}} | |||
{{Tricyclics}} | |||
[[Category:Phenothiazines]] | [[Category:Phenothiazines]] | ||
{{nervous-system-drug-stub}} |
Revision as of 20:26, 12 April 2015
File:Profenamine.svg | |
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code | |
Pharmacokinetic data | |
Protein binding | 93% |
Elimination half-life | 1 to 2 hours |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
ChEBI | |
ChEMBL | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C19H24N2S |
Molar mass | 312.473 g/mol |
3D model (JSmol) | |
| |
| |
(verify) |
Profenamine (INN, trade names Parsidol, Parsidan, Parkin), also known as ethopropazine (BAN), is a phenothiazine derivative used as an antiparkinsonian agent that has anticholinergic, antihistamine, and antiadrenergic actions. It is also used in the alleviation of the extrapyramidal syndrome induced by drugs such as other phenothiazine compounds, but, like other compounds with antimuscarinic properties, is of no value against tardive dyskinesia.